Gan_Gans, take a look at page 5, 2020 annual report.
My understanding is that it's pretty clear cut that they do have the OA patents.
I'm certainly not an audit/accounting expert here, but I believe the respiratory patent received a specific mention in 2021 report due to the *less than ideal* trial results, and Paradigm needing to specify how they are handling it from a valuation perspective.
Gan_Gans, take a look at page 5, 2020 annual report.My...
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.005(1.96%) |
Mkt cap ! $90.94M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 27.0¢ | 25.5¢ | $154.4K | 596.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 68618 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 5263 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |